Bright minds biosciences announces participation in upcoming scientific conferences and partnering events

Bright minds biosciences will present scientific posters about various programs in development, including bmb-101, bmb-201 and bmb-202 bright minds biosciences will participate in bio europe partnering event and chicago biocapital summit to present its innovation in neuroscience new york, oct. 03, 2024 (globe newswire) -- bright minds biosciences inc. (nasdaq: drug), a pioneering company focused on developing highly selective 5-ht2 agonists for the treatment of drug-resistant epilepsy, depression, and other cns disorders, is excited to announce its participation in the upcoming scientific conferences: neuroscience 2024 annual meeting, organized by the society for neuroscience (sfn), will take place in chicago, october 5–9. therapeutic development at ninds chicago, october 7, 2024.
DRUG Ratings Summary
DRUG Quant Ranking